138 related articles for article (PubMed ID: 35490586)
1. Genetic reprogramming of remnant duodenum may contribute to type 2 diabetes improvement after Roux-en-Y gastric bypass.
Sala P; Machado NM; Torrinhas RSMM; Fonseca DC; Ferreira BA; Ishida RK; Guarda IFMS; de Moura EGH; Sakai P; Santo MA; Heymsfield SB; Corrêa-Giannella ML; Waitzberg DL
Nutrition; 2022; 99-100():111631. PubMed ID: 35490586
[TBL] [Abstract][Full Text] [Related]
2. Roux-en-Y gastric bypass affects the expression of genes related to the intestinal folate metabolism pathway in obese women.
de Azevedo Muner Ferreira B; Fonseca DC; Sala P; Alves JTM; Prudêncio APA; Machado NM; Marques M; Barcelos S; Ishida RK; Guarda IFMS; De Moura EGH; Sakai P; Santo MA; de Miranda Torrinhas RSM; Waitzberg DL
Nutrition; 2023 Aug; 112():112054. PubMed ID: 37224573
[TBL] [Abstract][Full Text] [Related]
3. "Dual-remission" after Roux-en-Y gastric bypass surgery: Glycemic variability cannot always be improved in Chinese obese patients with type 2 diabetes.
Yu H; Zhou J; Bao Y; Pin Zhang ; Lu W; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1312-1319. PubMed ID: 26823091
[TBL] [Abstract][Full Text] [Related]
4. Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
Zhang H; Han X; Yu H; Di J; Zhang P; Jia W
Obes Surg; 2017 Jan; 27(1):134-142. PubMed ID: 27312346
[TBL] [Abstract][Full Text] [Related]
5. Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis.
Günthert SJ; Aksan A; Schröder O; Meyer G; Hausmann J; Stein J; Stier C
Surg Endosc; 2022 Aug; 36(8):5979-5985. PubMed ID: 35378626
[TBL] [Abstract][Full Text] [Related]
6. Duodenal long noncoding RNAs are associated with glycemic control after bariatric surgery in high-fat diet-induced diabetic mice.
Liang Y; Yu B; Wang Y; Qiao Z; Cao T; Zhang P
Surg Obes Relat Dis; 2017 Jul; 13(7):1212-1226. PubMed ID: 28366671
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Single-Arm Trial of Modified Long Biliopancreatic and Short Alimentary Limbs Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity.
Murad AJ; Cohen RV; de Godoy EP; Scheibe CL; Campelo GP; Ramos AC; de Lima RC; Pinto LEV; Coelho D; Costa HBF; Pinto ÍMP; Pereira T; Teófilo FRS; Valadão JA
Obes Surg; 2018 Mar; 28(3):599-605. PubMed ID: 28933045
[TBL] [Abstract][Full Text] [Related]
8. Type 2 Diabetes Remission After Roux-en-Y Gastric Bypass: Evidence for Increased Expression of Jejunal Genes Encoding Regenerating Pancreatic Islet-Derived Proteins as a Potential Mechanism.
Sala P; Torrinhas RS; Fonseca DC; Heymsfield S; Giannella-Neto D; Waitzberg DL
Obes Surg; 2017 Apr; 27(4):1123-1127. PubMed ID: 28213664
[TBL] [Abstract][Full Text] [Related]
9. Decreased visceral fat area correlates with improved total testosterone levels after Roux-en-Y gastric bypass in obese Chinese males with type 2 diabetes: a 12-month follow-up.
Liu F; Tu Y; Zhang P; Bao Y; Han J; Jia W
Surg Obes Relat Dis; 2018 Apr; 14(4):462-468. PubMed ID: 29254689
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Ghrelin Gene Expression in the Excluded Stomach of Obese Women with Type 2 Diabetes After Roux-en-Y Gastric Bypass in the SURMetaGIT Study.
Fonseca DC; Sala P; Singer J; Singer P; Torrinhas RS; Waitzberg DL
Obes Surg; 2018 Mar; 28(3):877-880. PubMed ID: 29307107
[TBL] [Abstract][Full Text] [Related]
11. Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2.
Proczko-Markuszewska M; Stefaniak T; Kaska Ł; Sledziński Z
Pol Przegl Chir; 2011 Feb; 83(2):81-6. PubMed ID: 22166285
[TBL] [Abstract][Full Text] [Related]
12. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
[TBL] [Abstract][Full Text] [Related]
13. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of Roux-en-Y versus single anastomosis gastric bypass.
Almalki OM; Lee WJ; Chong K; Ser KH; Lee YC; Chen SC
Surg Obes Relat Dis; 2018 Apr; 14(4):509-515. PubMed ID: 29555031
[TBL] [Abstract][Full Text] [Related]
15. Impact of perioperative management of glycemia in severely obese diabetic patients undergoing gastric bypass surgery.
Chuah LL; Miras AD; Papamargaritis D; Jackson SN; Olbers T; le Roux CW
Surg Obes Relat Dis; 2015; 11(3):578-84. PubMed ID: 25863535
[TBL] [Abstract][Full Text] [Related]
16. Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes.
Heshmati K; Harris DA; Aliakbarian H; Tavakkoli A; Sheu EG
Surg Obes Relat Dis; 2019 Dec; 15(12):2025-2032. PubMed ID: 31711946
[TBL] [Abstract][Full Text] [Related]
17. Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case-Control Study.
Anazco D; Ghusn W; Campos A; Cifuentes L; Fansa S; Tama E; Bublitz JT; Gala K; Hurtado MD; Olson JE; Acosta A
Obes Surg; 2023 Nov; 33(11):3502-3509. PubMed ID: 37798511
[TBL] [Abstract][Full Text] [Related]
18. Changes in bone quality after Roux-en-Y gastric bypass: A prospective cohort study in subjects with and without type 2 diabetes.
Blom-Høgestøl IK; Mala T; Kristinsson JA; Brunborg C; Gulseth HL; Eriksen EF
Bone; 2020 Jan; 130():115069. PubMed ID: 31593823
[TBL] [Abstract][Full Text] [Related]
19. Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes.
Flynn CR; Albaugh VL; Tamboli RA; Gregory JM; Bosompem A; Sidani RM; Winnick JJ
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G370-G374. PubMed ID: 31709832
[TBL] [Abstract][Full Text] [Related]
20. Insulin sensitivity is related to glycemic control in type 2 diabetes and diabetes remission after Roux-en Y gastric bypass.
Gavin TP; Ernst JM; Caudill SE; Dohm GL; Pories WJ; Dar M; Reed MA
Surgery; 2014 Jun; 155(6):1036-43. PubMed ID: 24856123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
